We’re in Liverpool for the annual National Cancer Research Institute (NCRI) Cancer Conference, sharing updates from the most exciting research on show.
In the fourth of our series of posts for Stand Up To Cancer, we focus on a clinical trial that’s finding faulty genes to improve breast cancer treatment.
New research points to a possible way to help personalise treatment for a type of childhood cancer.
An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.
What do you get when you combine scientists, a ‘Dragon’s Den’-style pitch, and £200,000 to fund cancer research?
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren’t. We explore why.
Category: Science blog July 21, 2016
Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.